chr5-75666984-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP6_Very_StrongBS2
The NM_001276713.2(ANKDD1B):c.1384C>T(p.Gln462Ter) variant causes a stop gained change. The variant allele was found at a frequency of 0.000406 in 1,477,880 control chromosomes in the GnomAD database, including 7 homozygotes. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: 𝑓 0.00039 ( 2 hom., cov: 32)
Exomes 𝑓: 0.00041 ( 5 hom. )
Consequence
ANKDD1B
NM_001276713.2 stop_gained
NM_001276713.2 stop_gained
Scores
2
1
1
Clinical Significance
Conservation
PhyloP100: 5.16
Genes affected
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -12 ACMG points.
BP6
Variant 5-75666984-C-T is Benign according to our data. Variant chr5-75666984-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 734732.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Homozygotes in GnomAd4 at 2 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ANKDD1B | NM_001276713.2 | c.1384C>T | p.Gln462Ter | stop_gained | 12/14 | ENST00000601380.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ANKDD1B | ENST00000601380.4 | c.1384C>T | p.Gln462Ter | stop_gained | 12/14 | 5 | NM_001276713.2 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000381 AC: 58AN: 152136Hom.: 2 Cov.: 32
GnomAD3 genomes
AF:
AC:
58
AN:
152136
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000802 AC: 67AN: 83506Hom.: 0 AF XY: 0.000954 AC XY: 41AN XY: 42960
GnomAD3 exomes
AF:
AC:
67
AN:
83506
Hom.:
AF XY:
AC XY:
41
AN XY:
42960
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000407 AC: 540AN: 1325628Hom.: 5 Cov.: 30 AF XY: 0.000547 AC XY: 355AN XY: 648474
GnomAD4 exome
AF:
AC:
540
AN:
1325628
Hom.:
Cov.:
30
AF XY:
AC XY:
355
AN XY:
648474
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000394 AC: 60AN: 152252Hom.: 2 Cov.: 32 AF XY: 0.000564 AC XY: 42AN XY: 74424
GnomAD4 genome
AF:
AC:
60
AN:
152252
Hom.:
Cov.:
32
AF XY:
AC XY:
42
AN XY:
74424
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
26
Asia WGS
AF:
AC:
3
AN:
3478
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Benign
FATHMM_MKL
Uncertain
D
Vest4
GERP RS
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at